Latest Information Update: 06 Jan 1997
At a glance
- Originator UCB Japan
- Class Antivirals
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 06 Jan 1997 Discontinued-preregistration for Viral infections in Japan (Ophthalmic)
- 09 Nov 1995 New profile
- 09 Nov 1995 Preregistration for Viral infections in Japan (Ophthalmic)